Diseases of the central nervous system of various origins, especially those related to cardiovascular diseases and disorders of metabolic processes in the brain, intoxication (particularly in post-traumatic conditions and phenomena of chronic cerebrovascular insufficiency), accompanied by the deterioration of intellectual-mental functions, reduction of motor activity;
Neurotic condition manifested boldenone undecylenate apathy, increased exhaustion, decreased psychomotor activity, in violation of attention, memory impairment;
Violations of learning processes ; depression of mild to moderate severity ; Psihorganicheskie syndromes that appear intellectual and memory impairment and apatiko-abulicheskimi phenomena and vyaloapaticheskih state in schizophrenia;
Spasmodic state ;
Obesity (alimentary constitutional genesis);
Prevention of hypoxia , increase resistance to stress, functional correction of the body under extreme conditions of professional activity in order to prevent the development of fatigue and increase mental and physical performance, the correction of circadian biorhythm cycle inversion “sleep-wake”;
Chronic alcoholism (to reduce fatigue phenomena, depression, intellectual-mental disorders).
Fenotropil used with caution in patients with severe organic lesions of the liver and kidneys, severe arterial hypertension, in patients with atherosclerosis, and patients who have had previous panic attacks, anxiety raptoidnye state or acute psychotic states, especially agitated, because of the possibility of anxiety exacerbation, panic, hallucinations and delusions, as well as in patients who are prone to allergic reactions to nootropics pyrrolidone group.
USE IN PREGNANCY AND LACTATION
Fenotropil should not be used during boldenone undecylenate pregnancy and breastfeeding due to lack of clinical trial data.
USE IN PEDIATRICS
Not recommended the appointment phenotropil children, due to lack of data of the drug in children.
DOSAGE AND ADMINISTRATION
Fenotropil administered orally, immediately after a meal. The dose and duration of treatment should be determined by your doctor. Doses vary depending on the characteristics of the patient. The average single dose of 150 mg (from 100 mg to 250 mg); average daily dose of 250 mg (from 200 mg to 300 mg). The maximum tolerated dose of – 750 mg per day. It is recommended to divide the daily dose into 2 doses. The daily dose to 100 mg taken once in the morning, and more than 100 mg daily dose is divided into two stages. Duration of treatment may range from 2 weeks to 3 months. The average duration of treatment is 30 days. If necessary, the course may be repeated after a month.
To improve performance – 100-200 mg once in the morning for 2 weeks (for athletes – 3 days).
The recommended duration of treatment for patients with alimentary-constitutional obesity is 30-60 days at a dose of 100-200 mg once daily (in the morning).
Do not take Fenotropil later than 15 hours.
Insomnia (in case of the drug within 15 hours). Some patients in the first 1-3 days of the drug agitation may occur, flushing of the skin, a feeling of warmth, increased blood pressure.
No cases of overdose were reported. Treatment: symptomatic therapy.
Interaction with other drugs
Fenotropil may increase the effects of drugs that stimulate the central nervous system, antidepressants, and neuroprotective drugs.
When excessive psycho-emotional exhaustion on the background of chronic stress and fatigue, chronic insomnia, acute administration boldenone undecylenate phenotropil the first day can cause a sharp need for sleep. Such patients on an outpatient basis should be advised to start taking the drug in exchange holidays.